rituximab
not tagged
['rituximab', 'lyma', 'cml', 'ritux']
long term (7yr) follow up of lyma trial - rituximab maintenance study after autosct in mcl by - continued pfs benefit, no os difference, and no increase of relapse after r discontinuation, but continued unmet need in pod24 population #icml23 #17icml 
Heme/Onc fellow @UCCancerCenter interested in aggressive lymphoma, novel therapeutics, and cellular therapies #lymsm #TcellRx. Views are my own.